HeartBeam, AccurKardia partner to speed up cardiac diagnosis

ECG diagnostics software platform AccurKardia and cardiac medical technology company HeartBeam are joining forces to make AccurKardia’s ECG analysis software available on HeartBeam’s devices.  HeartBeam’s cable-free, 12-lead ECG system captures electrical signals from the heart from three directions to assess arrhythmias.  The platform is designed for portable devices so physicians can identify cardiac health trends…

Read Full News

International Space Station National Lab supports cardiac, genetic research

When NASA’s SpaceX Crew-9 launched to the International Space Station (ISS) on Sept. 28, one of the ISS National Lab-sponsored investigations included a student-led project designed to investigate the consequences of radiation and the space environment on gene-editing mechanisms. In a statement, the ISS National Laboratory said that data from the project, led by principal…

Read Full News

Cardio Diagnostics Holdings partners with Navierre for cardiac testing

AI-enabled cardiovascular company Cardio Diagnostics Holdings announced it is partnering with care navigation platform Navierre to make assessing risk and diagnosing heart diseases more accessible.  Cardio Diagnostics Holdings’ AI solutions, Epi+GenCHD and PrecisionCHD, use blood samples to provide patients with personalized information regarding their risk for coronary heart disease based on epigenetic and genetic science. …

Read Full News